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Abstract
Background: The aim of the present study of the general population was to identify the best predictor of metabolic
risk among the body index variables evaluated with dual-energy X-ray absorptiometry (DEXA) or anthropometric indices
including the waist to height ratio (WHtR).
Patients and Methods: Data from the Korean National Health and Nutrition Examination Survey 2008–2011 were used
for the analyses. As a result, 15,965 participants were included in this study. The body mass (BM) index was calculated as
the body weight divided by the height squared. The WHtR was calculated as the waist circumference divided by height.
Body composition indices such as lean mass (LM), fat mass (FM), trunk fat mass (TFM), and bone mineral content (BMC)
were determined by using DEXA. Skeletal muscle mass (SM) was defined as the sum of the lean soft masses of both
extremities. The LM, FM, BMC, TFM, and SM indices were calculated by dividing the total LM, total FM, total BMC, TFM, or
SM by the height squared.
Results: The WHtR had the highest area under the curve (AUC) and was the best predictor of metabolic syndrome for
both sexes. In addition, the WHtR had the highest AUCs for components of metabolic syndrome (male: AUC 0.823, 95 %
confidence interval [CI] 0.814–0.832; female: AUC 0.870, 95 % CI 0.863–0.877). There was a small statistically significant
difference in AUC between WHtR and the other indices. Multivariate logistic regression showed that male participants in
the second, third, and fourth quartiles had a 4.0 (95 % CI, 3.1–5.2), 9.6 (95 % CI, 7.5–12.3), and 36.1 (95 % CI, 28.0–46.4)
times increased risk of metabolic syndrome compared with patients in the first quartile and female participants in the
second, third, and fourth quartiles had a 4.3 (95 % CI, 3.1–6.0), 18.0 (95 % CI, 13.3–24.5), and 58.5 (95 % CI, 42.9–79.9) times
increased risk of metabolic syndrome compared with patients in the first quartile.
Conclusion: Among the BM, FM, LM, SM, TFM, and WHtR indices, WHtR is most useful to predict the presence of
metabolic syndrome and insulin resistance in the Korean population.
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Background
Metabolic syndrome is a pathologic condition character-
ized by elevated waist circumference (WC), elevated tri-
glyceride level, reduced high-density lipoprotein
cholesterol level, elevated blood pressure, and elevated
fasting glucose level [1]. Metabolic syndrome is a risk
factor for type 2 diabetes mellitus, and cardiovascular
disease is a common health problem in patients with this
condition; as a result, metabolic syndrome is associated
with a risk of death and complications caused by cardio-
vascular disease and diabetes mellitus [2, 3]. Early detec-
tion and proper management of metabolic syndrome are
important for prevention of cardiometabolic problems
[4, 5].
Metabolic syndrome is closely related to obesity. Body
mass index (BMI) and WC are well-known indices of
general and abdominal obesity, respectively, and WC is a
component of metabolic syndrome. However, various
studies have reported that the waist to height ratio
(WHtR), which considers ethnicity and height is more
closely associated with insulin resistance and clinical
outcomes in both adults and children [6–9].
Classic body indices such as BMI, WC, and WHtR,
have been used to assess metabolic problems and have
several advantages as simple rapid screening tools. How-
ever, they do not provide the distribution between skel-
etal muscle mass and fat. Body composition analyzers
such as multi-frequency bioimpedance analysis and
dual-energy X-ray absorptiometry (DEXA), can differen-
tiate between muscle mass and fat and the distribution
between limb and trunk.
Recent studies using body composition analyzers have
reported that fat mass (FM) is positively correlated with
metabolic syndrome [10–16]. However, some large-scale
studies did not show that indices using body compos-
ition analyzers are superior to classic indices [17–19].
The aim of the present study of the general population
was to identify the best predictor of metabolic risk
among the body index variables evaluated with DEXA or
anthropometric indices including the WHtR.
Patients and Methods
Study population
Data from the Korean National Health and Nutrition
Examination Survey (KNHANES) 2008–2011 were used
for the analyses. The KNHANES is a nationwide, multi-
stage stratified survey of a representative sample of the
entire South Korean population conducted by the Korea
Centers for Disease Control and Prevention. The total
number of participants in KNHANES was 37,753. Those
who had no information regarding renal function and/or
metabolic markers (n = 14,533), had no information re-
garding body composition (n = 6,019), or were younger
than 18 years of age (n = 1,236) were excluded. As a
result, 15,965 participants were included in this study.
This study was approved by the institutional review board
of Yeungnam University Hospital (YUH-14-0454-O56).
The board waived the need for informed consent.
Study variables
Clinical and laboratory data collected during the health
examination included age, sex, education level, smoking
behavior, mean daily alcohol intake, physical activity, WC
(cm), WHtR, BMI (kg/m2), lean mass (LM) index (kg/m2),
FM index (kg/m2), trunk FM (TFM) index (kg/m2), skeletal
muscle mass (SM) index (kg/m2), bone mineral content
(BMC) index (kg/m2), systolic blood pressure (mmHg),
diastolic blood pressure (mmHg), fasting glucose level
(mg/dL), total cholesterol level (mg/dL), triglyceride level
(mg/dL), high-density lipoprotein (mg/dL), and estimated
glomerular filtration rate (eGFR) (mL/min/1.73 m2).
Fasting glucose, total cholesterol, triglyceride, high-
density lipoprotein levels were measured by a Hitachi
Automatic Analyzer 7600 (Hitachi, Japan) by the enzym-
atic method (Sekisui Co., Japan). Serum creatinine level
was measured by using a Hitachi Automatic Analyzer
(alkaline picrate, Jaffé kinetic). The eGFR was calculated
using the Chronic Kidney Disease Epidemiology Collab-
oration equation [20]. Chronic kidney disease was de-
fined as an eGFR <60 mL/min/1.73 m2 or dipstick
proteinuria (≥1+). Physical activity was assessed by self-
reported questionnaires that examined frequency, inten-
sity, and time per day spent on physical activity. We
calculated metabolic equivalent-minutes per week (MET
min/wk) using a physical activity calculating Inter-
national Physical Activity Questionnaire and divided into
3 groups (<3000 MET min/wk, 3000–6000 MET min/wk,
and ≥6000 MET min/wk) [21]. We defined smoking status
in 2 respects: “smoking status” and “smoking amount”
(PYR, average daily smoking amount [pack] × smoking
period [year]). The cohorts were divided into 4 groups ac-
cordingly: heavy smoker (current smoker, ≥30 PYR), inter-
mediate smoker (current smoker, <30 PYR), ex-smoker,
and non-smoker [22]. Mean daily alcohol intake was de-
fined as the Korean version of a “standard drinking”,
which was based on WHO classification [23, 24]. We
classified mean daily alcohol intake into 3 categories:
abstinence (not having had a drink containing alcohol
within the last year), moderate drinking (women, 0.1–
19.99 g pure alcohol/day; men, 0.1–39.99 g pure
alcohol/day), and heavy drinking (women, ≥20 g pure
alcohol/day; men, ≥40 g pure alcohol/day). Weight
and height were measured by well-trained medical
professionals. Standing height was measured with the
subject facing directly ahead with shoes off, feet to-
gether, arms by the sides, and heels, buttocks, and
upper back in contact with the wall using a SECA
225 (SECA, Hamburg, Germany). Weight was
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measured using a GL-6000-20 scale (Cass, Seoul,
Korea). WC was measured at the midpoint between
the bottom of the rib cage and the top of the iliac
crest. WHtR was calculated as WC divided by height.
Body composition measurements such as LM, FM,
and BMC, were determined by using DEXA (QDR
4500A; Hologic Inc., Waltham, MA, USA). SM was
defined as the sum of the lean soft masses of both
extremities. The LM, FM, BMC, TFM, and SM indi-
ces were calculated by dividing the total LM, total
FM, total BMC, TFM, or SM by the height squared
(kg/m2).
Metabolic syndrome was defined by the current cri-
teria in the National Cholesterol Education Program
Adult Treatment Panel III guidelines [1]. Elevated blood
pressure was defined as a systolic or diastolic blood
pressure of ≥130/85 mmHg, a self-reported history of
hypertension, or the use of anti-hypertensive drugs. Ele-
vated blood glucose was defined as a fasting blood glu-
cose level ≥100 mg/dL or a self-reported history of
diabetes mellitus. A low high-density lipoprotein choles-
terol level was defined as <40 mg/dL in men and
<50 mg/dL in women. Elevated triglyceride was defined
as a serum triglyceride ≥150 mg/dL. Abdominal obesity
was defined as a WC >90 cm in men and >80 cm in
women. Metabolic syndrome was defined as the pres-
ence of ≥3 components of metabolic syndrome.
Statistical analyses
The data were analyzed by SPSS version 19 (SPSS,
Chicago, IL, USA). The distribution of continuous
variables was checked by using the Kolmogorov–
Smirnov test. Non-parametric variables were
expressed as median (interquartile range) and com-
pared by using the Mann–Whitney U–test. Categor-
ical variables were expressed as counts and
percentages. Pearson χ2 test or Fisher exact test was
used to analyze categorical variables. Multivariate lo-
gistic regression was used to estimate the odds ratios,
and the 95 % confidence intervals were used to deter-
mine the relationship between variables and metabolic
syndrome. Covariates that were considered potential
confounders (age, smoking, physical activity, and
mean daily alcohol intake) were included in multivari-
ate models. Model 1 was unadjusted, model 2 was ad-
justed for age, smoking, physical activity, and mean
daily alcohol intake. Metabolic syndrome components
were analyzed using analysis of covariance. Discrimin-
ation, which is the ability of the model to differentiate
between participants who have metabolic syndrome
and those who do not, was examined using the area
under the receiver operating characteristic curve
(AUROC). AUROC analysis was also performed to
calculate cutoff values, sensitivity, and specificity. The
best cutoff risk point was defined from the maximum
of the Youden index in the AUROC. The statistical
significance between the areas under indices receiver
operating characteristic curves was calculated by the
DeLong method. The AUROC was calculated by using
MedCalc version 11.6.1.0 (MedCalc, Mariakerke,
Belgium). The level of statistical significance was set
at P < 0.05.
Results
Baseline characteristics of participants
The mean age of the study participants was 48 (36–62)
years for men (n = 6875) and 48 (36–61) years for
women (n = 9090) (Table 1). The number of participants
with education levels of up to elementary school, middle
school, high school, and college or higher was 1,263
(18.4 %), 871 (12.7 %), 2,471 (35.9 %), and 2,231
(32.5 %), respectively, in men, and 3,033 (33.4 %), 965
(10.6 %), 2,975 (32.7 %), and 2,070 (22.8 %), respectively,
in women (P < 0.001). The education level was higher in
men than in women. The male participants had higher
body indices, including WC, WHtR, BMI, LM index,
BMC index, SM index, and TFM index, than the female
participants. The male participants also had significantly
higher blood pressure, fasting glucose levels, triglyceride
levels, and lower levels of high-density lipoprotein chol-
esterol than the female participants. In addition, the
male participants had a higher prevalence of heavy
drinking, current smoking, and chronic kidney disease
than the female participants.
Comparison of the prediction of metabolic syndrome
among the body indices
The body indices for prediction of metabolic syn-
drome were explored using AUROC curves, as shown
in Additional file 1: Table S2. The WHtR had the
highest area under the curve (AUC) (male: 0.823,
95 % CI 0.814–0.832; female: 0.870, 95 % CI 0.863–0.877)
and was the best predictor of metabolic syndrome for
both sexes. The sensitivity of predicting metabolic syn-
drome by WHtR was 74.0 % for the male participants and
83.3 % for the female participants, and the specificity was
75.8 % for the male participants and 76.5 % for the female
participants. Considering the indices with an AUC < 0.6 to
be poor measures, the BMC index had the lowest
AUC (<0.6) and was poorest measure in predicting
metabolic syndrome in both sexes.
In addition, the WHtR had the highest AUCs for
components of metabolic syndrome, including ele-
vated fasting glucose level, elevated blood pressure,
elevated triglyceride level, and reduced high-density
lipoprotein cholesterol level. In males, the SM and
BMC indices were poor measures in predicting all
metabolic syndrome components (Table 2). The LM
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index was predictive for only elevated triglyceride
level among the metabolic syndrome components. In
females, the BMC index was a poor measure in pre-
dicting all metabolic syndrome components. The SM
index was predictive for only elevated fasting glucose
and blood pressure levels among the metabolic syn-
drome components.
Presence of metabolic syndrome according to WHtR
quartiles
The WHtRs were divided into 4 quartiles. The quartiles
for male participants were as follows: first quartile
(Q1), ≤0.4603; second quartile (Q2), 0.4604–0.4981;
third quartile (Q3), 0.4982–0.5343; and fourth quartile
(Q4), ≥0.5344. The quartiles for the female participants
Table 1 Clinical characteristics of the participants
Characteristics Males (n = 6875) Females (n = 9090) P value*
Age 48 (36–62) 48 (36–61) 0.748
WC (cm) 84.2 (78.2–90.2) 77.8 (71.1–85.0) <0.001
WHtR 0.497 (0.459–0.533) 0.497 (0.450–0.548) <0.001
BMI (kg/m2) 23.9 (21.8–25.9) 23.0 (20.9–25.4) <0.001
LM index (kg/m2) 17.4 (16.3–18.6) 14.5 (13.4–15.6) <0.001
FM index (kg/m2) 5.3 (4.0–6.5) 7.6 (6.2–9.1) <0.001
BMC index (kg/m2) 0.88 (0.81–0.95) 0.80 (0.71–0.88) <0.001
SM index (kg/m2) 7.6 (7.1–8.2) 5.8 (5.4–6.3) <0.001
TFM index (kg/m2) 8.7 (8.1–9.3) 7.5 (6.9–8.1) <0.001
SBP (mmHg) 116.5 (107.5–128.5) 111.9 (101.9–126.9) <0.001
DBP (mmHg) 76.5 (69.3–84.5) 71.9 (66.9–78.9) <0.001
Fasting glucose (mg/dL) 94 (88–103) 92 (86–99) <0.001
Total cholesterol (mg/dL) 183 (161–208) 185 (163–210) <0.001
HDL cholesterol (mg/dL) 48 (41–56) 53 (45–62) <0.001
Triglyceride (mg/dL) 123 (84–187) 94 (65–140) <0.001
Smoking <0.001
Heavy smoker 761 (11.1 %) 28 (0.3 %)
Intermediate smoker 3645 (53.0 %) 778 (8.6 %)
Ex-smoker 1059 (15.4 %) 185 (2.0 %)
Non-smoker 1279 (18.6 %) 7935 (87.3 %)
No data 42 (0.6 %) 68 (0.7 %)
Mean daily alcohol intake <0.001
Abstinence 1127 (16.4 %) 3387 (37.3 %)
Moderate drinking 4107 (59.7 %) 5138 (56.5 %)
Heavy drinking 1591 (23.1 %) 494 (5.4 %)
No data 50 (0.7 %) 71 (0.8 %)
Exercise <0.001
≥ 6000 MET min/wk 1666 (24.2 %) 1479 (16.3 %)
3000 ~ 6000 MET min/wk 1466 (21.3 %) 1456 (16.0 %)
<3000 MET min/wk 3672 (53.4 %) 6039 (66.4 %)
No data 71 (1.0 %) 116 (1.3 %)
Metabolic syndrome 2159 (31.4 %) 2932 (32.3 %) 0.258
eGFR (mL/min/1.73 m2) 93.7 (83.2–104.6) 101.3 (89.0–113.9) <0.001
CKD 307 (4.5 %) 283 (3.1 %) <0.001
Data are expressed as numbers (percentages) for categorical variables and median (interquartile range) for continuous variables
Abbreviations: WC waist circumference; WHtR waist to height ratio; BMI body mass index; LM lean mass; FM fat mass; BMC bone mineral content; SM skeletal
muscle mass; TFM trunk fat mass; SBP systolic blood pressure; DBP diastolic blood pressure; HDL high-density lipoprotein; MET min/wk metabolic equivalent-minutes per
week; eGFR estimated glomerular filtration rate; CKD chronic kidney disease
*Statistical significance was tested by using the Mann–Whitney U–test for continuous variables and Pearson χ2 test or Fisher exact test for categorical variables
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were as follows: Q1, ≤0.4520; Q2, 0.4521–0.5002; Q3,
0.5003–0.5510; and Q4, ≥0.5511. In model 2, male par-
ticipants in Q2, Q3, and Q4 had a 4.0 (95 % CI 3.1–5.2),
9.6 (95 % CI 7.5–12.3), and 36.1 (95 % CI 28.0–46.4) times
increased risk of metabolic syndrome compared with pa-
tients in Q1 and female participants in the Q2, Q3, and
Q4 had a 4.3 (95 % CI 3.1–6.0), 18.0 (95 % CI 13.3–24.5),
and 58.5 (95 % CI 42.9–79.9) times increased risk of meta-
bolic syndrome compared with patients in Q1 (Table 3).
In addition, WHtR quartiles had highest odd ratios for
metabolic syndrome among BMI, FM index, TFM index,
and WHtR in both Model 1 and Model 2.
The patients had more metabolic syndrome components
on both univariate and multivariate analyses as the WHtR
quartiles increased (Table 4). In addition, the WHtR quar-
tiles had the highest odds ratios for predicting all metabolic
syndrome components except elevated blood pressure in
males (Additional file 1: Table S3). Logistic regression
analyses by using a cut-off value of WHtR < 0.5 as an inter-
national guideline showed a significant association between
WHtR < 0.5 and metabolic syndrome or metabolic
syndrome components (Additional file 1: Table S4).
Discussion
The present study demonstrates that WHtR had the
highest AUC and was the best predictor of metabolic
syndrome and components of metabolic syndrome for
both sexes. Univariate and multivariate analyses revealed
that WHtR quartiles were associated with metabolic syn-
drome in the general population. In addition, the WHtR
quartiles had the highest odds ratio for predicting most
metabolic syndrome components (elevated fasting glu-
cose, blood pressure, triglyceride level, and decreased
high-density lipoprotein level) among the other indices
in both sexes. Logistic regression analyses with a cut-off
value of WHtR < 0.5 as an international guideline
showed a significant association with metabolic syn-
drome or metabolic syndrome components.
Obesity is a well-known risk factor for and component
of metabolic syndrome. Central visceral fat has shown
stronger associations with cardiovascular disease risk
and metabolic syndrome than subcutaneous fat [25, 26].
Previous studies have demonstrated that WC is closely
correlated to reference methods such as computed tom-
ography or magnetic resonance imaging and is a more
predictive surrogate for metabolic syndrome than BMI
[6, 7, 9, 27, 28]. Height is inversely associated with chol-
esterol level, and WC would be needed to adjust for
height [29]. Therefore, WHtR may be a more predictive
measure than classic body indices such as WC and BMI.
A meta-analysis showed the superiority of WHtR [9].
The present study compared the anthropometric
(WHtR and BMI) and body composition indices. Our re-
sults shows that body indices using a body composition
analyzer have no advantage over classic anthropometric
indices. Our results showed that WHtR had the highest
Table 2 The AUROC of each of the indices for the presence of metabolic syndrome components
Variables Elevated FG Elevated BP Elevated TG Decreased HDL-C
Males AUC (95 % CI) AUC (95 % CI) AUC (95 % CI) AUC (95 % CI)
BMI 0.611 (0.600–0.623)* 0.615 (0.603–0.627)* 0.672 (0.660–0.683)* 0.634 (0.622–0.645)*
FM index 0.613 (0.601–0.624)* 0.625 (0.614–0.637)* 0.679 (0.668–0.690)** 0.642 (0.630–0.653)**
LM index 0.571 (0.560–0.583)* 0.569 (0.557–0.581)* 0.611 (0.599–0.623)* 0.587 (0.575–0.599)*
BMC index 0.536 (0.525–0.548)* 0.517 (0.505–0.529)* 0.531 (0.519–0.543)* 0.540 (0.528–0.552)*
SM index 0.505 (0.493–0.517)* 0.506 (0.494–0.518)* 0.572 (0.561–0.584)* 0.546 (0.534–0.558)*
TFM index 0.620 (0.609–0.632)* 0.615 (0.604–0.627)* 0.631 (0.619–0.642)* 0.614 (0.602–0.625)*
WHtR 0.685 (0.674–0.696) 0.677 (0.665–0.688) 0.693 (0.682–0.704) 0.657 (0.644–0.667)
Females AUC (95 % CI) AUC (95 % CI) AUC (95 % CI) AUC (95 % CI)
BMI 0.689 (0.679–0.698)* 0.693 (0.683–0.703)* 0.688 (0.678–0.698)* 0.640 (0.630–0.650)*
FM index 0.665 (0.655–0.674)* 0.676 (0.666–0.686)* 0.680 (0.670–0.689)* 0.627 (0.617–0.637)*
LM index 0.670 (0.660–0.680)* 0.670 (0.660–0.679)* 0.650 (0.640–0.660)* 0.621 (0.611–0.631)*
BMC index 0.550 (0.540–0.560)* 0.625 (0.615–0.635)* 0.570 (0.559–0.580)* 0.534 (0.524–0.544)*
SM index 0.615 (0.605–0.625)* 0.604 (0.594–0.614)* 0.597 (0.587–0.607)* 0.595 (0.585–0.605)*
TFM index 0.690 (0.680–0.699)* 0.684 (0.674–0.693)* 0.664 (0.654–0.674)* 0.621 (0.611–0.631)*
WHtR 0.735 (0.726–0.744) 0.776 (0.768–0.785) 0.738 (0.729–0.747) 0.671 (0.662–0.681)
Abbreviations: AUROC area under the receiver operating characteristic curve; FG fasting glucose; BP blood pressure; TG triglyceride; HDL-C high density lipoprotein
cholesterol; AUC area under the curve; CI confidence interval; BMI, body mass index; FM fat mass; LM lean mass; BMC bone mineral content; SM skeletal muscle
mass; TFM trunk fat mass; WHtR waist to height ratio
*P < 0.001 compared with the WHtR
**P <0.01 compared with the WHtR
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AUC for predicting metabolic syndrome among other
body indices including BMI, FM, LM, SM, BMC, and
TFM for both sexes. Logistic regression analyses
showed that the WHtR quartiles had the highest odds
ratio for predicting metabolic syndrome or each com-
ponent among the BMI, FM index, TFM index, and
WHtR. There was a significant difference in numbers
of metabolic syndrome components using the general
linear model and these data compensate for the weak-
ness of the dichromatic category for metabolic syn-
drome. Our results show that body indices measured
using the body composition analyzer have no advan-
tage over classic anthropometric indices. Zhang et al.
enrolled Asians and showed that the sensitivity and
specificity of WHtR were 75.9 % and 52.7 % in males
and 67.8 % and 62.5 % in females, respectively [18].
The values in their study were lower than those in
the present study, while the cut-off values in their
study were similar to those in the present study.
Classic body indices cannot distinguish between fat and
other components. Body composition analyzers such as
bioimpedance analysis and DEXA, measure FM and free-
fat mass, which include BMC and LM. These indices may
be a more optimal marker for prediction of metabolic syn-
drome or insulin resistance than classic indices. Kim et al.
showed that the FMI evaluated with bioimpedance analysis
was the most strongest predictor of metabolic syndrome
among Korean men [14]. Namwongprom et al. enrolled
Thai adults and showed that the android-to-gynoid FM ra-
tio calculated by using DEXA was more predictive in the
diagnosis of metabolic syndrome than either the WC or
BMI [15]. A previous study in a Turkish population
showed that the WHtR is the most predictive indicator
among the anthropometric indices; however, visceral fat
measured with bioimpedance analysis is a more sensitive
variable than the WHtR [16]. However, many studies did
not show stronger associations between body composition
indices and metabolic syndrome and/or components of
metabolic syndrome than classic indices [18, 30–34].
Bioimpedance analysis or DEXA can measure the exact
FM. Although FM is associated with development of meta-
bolic syndrome, there have been controversies regarding
the advantage of FM in prediction of metabolic syndrome.
Many studies have shown that FM has no advantage over
classic body indices [18, 30–32]. Some recent studies en-
rolled migrant Asian Indian, Chinese, or multiethnics par-
ticipants and compared various anthropometric indices
with indices measured with DEXA [17–19]. However,
those studies did not show a superiority of the indicators
measured with body composition analyzers over either the
WC or WHtR. Bosy-Westphal et al. suggested that the in-
accuracies of impedance measurement may be associated
with discrepancies among studies [35]. DEXA is a refer-
ence method for measurement of FM. However, simple
trunk or total FM cannot differentiate between subcutane-
ous and visceral fat. In addition, previous studies have
shown that an increase in LM may be associated with an
increase in the prevalence of metabolic syndrome. LM
plays an important role in maintenance of systemic glucose
metabolism [36]. Many clinicians believe that LM may be a
protective effect of development of metabolic syndrome.
Previous studies have shown that an increase in LM is
positively associated with the risk of developing insulin re-
sistance and metabolic syndrome [29, 33]. Although the
exact mechanism for positive correlation remains poorly
understood, its association may be linked to a paradoxical
decrease in LM to metabolize glucose for energy as LM in-
creases [37]. These findings demonstrate that indices using
body composition analyzers have no advantage over classic
body indices.
A systematic review of many prospective or cross-
sectional studies and involving many ethnic groups sug-
gested that 0.5 is an appropriate boundary value for
Table 3 Odds ratios for metabolic syndrome according to the
quartiles of variable indices
Q1 Q2 Q3 Q4
Males
Model 1
BMI – 3.0 (2.4–3.7) 6.0 (5.0–7.4) 17.3 (14.2–21.0)
FM index – 3.7 (3.0–4.6) 7.9 (6.4–9.7) 16.5 (13.5–20.3)
TFM index – 2.2 (1.8–4.8) 4.0 (3.4–4.8) 9.6 (8.1–11.5)
WHtR – 4.4 (3.4–5.7) 11.5 (9.0–14.7) 44.3 (34.6–56.7)
Model 2
BMI – 3.5 (2.8–4.3) 7.7 (6.2–9.5) 28.3 (22.7–35.1)
FM index – 3.8 (3.0–4.7) 8.1 (6.6–10.0) 20.0 (16.1–24.8)
TFM index – 2.5 (2.1–3.1) 4.7 (3.9–5.7) 12.3 (10.2–14.9)
WHtR – 4.0 (3.1–5.2) 9.6 (7.5–12.3) 36.1 (28.0–46.4)
Females
Model 1
BMI – 3.8 (3.1–4.7) 9.9 (8.2–12.0) 27.1 (22.3–32.8)
FM index – 3.2 (2.7–3.9) 7.7 (6.5–9.2) 18.7 (15.6–22.2)
TFM index – 2.6 (2.2–3.1) 5.5 (4.7–6.5) 14.9 (12.7–17.5)
WHtR – 6.2 (4.6–8.5) 33.0 (24.5–44.4) 129.3 (95.7–174.6)
Model 2
BMI – 3.4 (2.7–4.2) 8.3 (6.7–10.2) 25.8 (20.8–32.0)
FM index – 3.5 (2.8–4.3) 7.0 (5.8–8.6) 18.4 (15.0–22.4)
TFM index – 2.2 (1.8–2.6) 4.1 (3.4–4.9) 12.4 (10.3–14.9)
WHtR – 4.3 (3.1–6.0) 18.0 (13.3–24.5) 58.5 (42.9–79.9)
Model 1 was unadjusted, whereas model 2 was adjusted for age, mean daily
alcohol intake, smoking, and physical activity. Variables were expressed as
odds ratio (95 % confidence interval), and odds ratios were calculated for Q1
Abbreviations: BMI body mass index; FM fat mass; TFM trunk fat mass; WHtR
waist to height ratio; CI confidence interval; Q1 first quartile; Q2 second quartile;
Q3 third quartile; Q4 fourth quartile
Statistical significance was defined as P < 0.001 for all analyses
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predicting cardiovascular disease and diabetes mellitus
in both sexes [38]. Therefore, clinical practitioners sim-
ply recommend that “your waist circumference should
be less than half your height” [19]. The review with 147
individual analyses showed that the mean AUROC
values for predicting metabolic syndrome were approxi-
mately 0.704, 0.693, and 0.670 for the WHtR, WC, and
BMI, respectively. The review showed that the WHtR
had the highest AUROC value followed by the WC, and
then the BMI; however, the difference in the AUROC
was small. The AUROC value for predicting metabolic
syndrome, as well as the differences in AUROC between
the WHtR and other indices, was greater in our study
than in the previous review. In addition, our cut-off
value was similar to that of the review. Therefore, the
criteria for other population groups are applicable to the
Korean population. In our data, logistic regression ana-
lyses by using a cut-off value of WHtR < 0.5 showed a
significant association between WHtR < 0.5 and meta-
bolic syndrome or metabolic syndrome components.
The present study was based on a sub-sample of a
nationwide representative survey. Approximately
57.7 % of the total cohort were excluded from the
study cohort. Additional file 1: Table S1 shows the
baseline characteristics of the total cohort. Age and
education level were lower in the total cohort than in
the study cohort. Concerning the mean daily alcohol
intake, a higher abstinence and lower heavy drinking
was found in the total cohort than in the study co-
hort. The number of non-smokers was higher in the
total cohort than in the study cohort. The amount of
exercise was similar between the two cohorts. The
age of participants was lower in the total cohort than
in the study cohort. The participants’ age may be as-
sociated with the differences in alcohol drinking, edu-
cation level, and smoking status. The total cohort
included 8,995 participants who were younger than
18 years. This exclusion may have caused older age in
the study cohort than in the total cohort.
The present study has a number of limitations. First, it is
limited by its cross-sectional nature and ethnic differences
were not evaluated. This study design showed associations
between the indices and metabolic diseases but could not
establish the causality between the indices and metabolic
syndrome, and the ability of the indices to predict meta-
bolic diseases. Second, the present study has the probability
of recall bias from a self-reporting questionnaire survey.
The impact of these limitations is reduced by the large
sample size in the present study, but did not offset the
cross-sectional nature of the study. A prospective study in-
cluding follow-up data is needed to show the cause-and-
effect relations between indices and metabolic diseases.
Conclusion
Body indices using body composition analyzers have no
advantage over classic body indices such as BMI and
WHtR. Among the classic body indices, WHtR is most
useful to predict the presence of metabolic syndrome in
the Korean population. In addition, it is really cheap and
safe, especially if compared with DEXA.
Table 4 Number of metabolic syndrome components by the WHtR quartile
Q1 Q2 Q3 Q4
Males
Model 1
Mean (95 % CI)* 0.711 (0.657–0.765) 1.369 (1.315–1.423) 2.050 (1.996–2.104) 3.067 (3.013–3.121)
Model 2
Mean* 0.830 (0.774–0.885) 1.387 (1.334–1.441) 1.998 (1.945–2.052) 2.997 (2.923–3.032)
Model 3
Mean* 0.883 (0.780–0.985) 1.406 (1.295–1.518) 2.010 (1.894–2.125) 3.014 (2.906–3.123)
Females
Model 1
Mean (95 % CI)* 0.538 (0.494–0.581) 1.176 (1.132–1.220) 2.335 (2.291–2.379) 3.288 (3.244–3.331)
Model 2
Mean* 0.840 (0.794–0.885) 1.255 (1.214–1.297) 2.220 (2.178–2.262) 3.011 (2.966–3.056)
Model 3
Mean* 0.739 (0.603–0.876) 1.154 (1.016–1.291) 2.156 (2.007–2.304) 2.921 (2.777–3.065)
Model 1 was unadjusted, whereas model 2 was adjusted for age, mean daily alcohol intake, smoking, and physical activity. Model 3 was adjusted for age, mean
daily alcohol intake, smoking, and physical activity and accounted for the complex sampling design and appropriate sampling weight of the national survey
Abbreviations: WHtR waist to height ratio; CI confidence interval; Q1 first quartile; Q2 second quartile; Q3 third quartile; Q4 fourth quartile
*Mean (95 % CI) were calculated by using analysis of covariance and statistical significance was defined as P < 0.001 for all analyses
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Additional file
Additional file 1: Table S1. Baseline characteristics of the total cohort.
Table S2. Comparison of AUROC for prediction of metabolic syndrome
among variable indices. Table S3. Odds ratios for metabolic syndrome
components according to the quartiles of variable indices. Table S4.
Odds ratios for metabolic syndrome components according to the
quartiles of variable indices. (DOCX 29 kb)
Abbreviations
WC: Waist circumference; BMI: Body mass index; WHtR: Waist to height ratio;
DEXA: Dual-energy X-ray absorptiometry; FM: Fat mass; KNHANES: Korean
National Health and Nutrition Examination Survey; LM: Lean mass; TFM: Trunk fat
mass; BMC: Bone mineral content; eGFR: Estimated glomerular filtration rate; MET
min/wk: Metabolic equivalent-minutes per week; PYR: Average daily smoking
amount [pack] × smoking period [year]; CI: Confidence interval; AUROC: Area
under the receiver operating characteristic curve; Q1: First quartile; Q2: Second
quartile; Q3: Third quartile; Q4: Fourth quartile.
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